United States Gynecology Robotic Surgery Market, By Type ; By Application ; By End User, Trend Analysis, Competitive Landscape & Forecast, 2022-2028

United States Gynecology Robotic Surgery Market Size to Cross USD 3.2 billion by 2028

United States gynecology robotic surgery market is growing because of increasing demand for minimally invasive surgeries over open surgeries in the country.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, expects United States Gynecology Robotic Surgery Market size to grow at a CAGR of 15.8% during the forecast period between 2022 and 2028 to reach a value of USD 3.21 billion by 2028. During the last three decades, minimally invasive surgery (MIS) has become a notable medical advancement. It revolutionized surgery by offering well-proven advantages over traditional open surgery, including reduced surgical trauma and incision-related complications such as surgical-site infections, postoperative discomfort, and hernia, as well as shorter hospital stays and improved cosmetic outcomes. Traditional laparoscopy, on the other hand, has limitations, including a two-dimensional (2D) monitor that limits in-depth perception, camera instability, limited range of motion, and steep learning curves.

United States Gynecology Robotic Surgery Market - Overview

In recent years, robotic surgery has grown in popularity, particularly in the field of benign hysterectomy. In gynecology, a hysterectomy is a regular procedure. Every year, about 600,000 hysterectomies are performed in the United States, with 84% of these being for non-cancerous tumors. In comparison to traditional laparoscopic methods, the da Vinci robotic system has gained widespread popularity in gynecology over the years due to improved visibility and dexterity. With the approval of the da Vinci surgical system for use in gynecologic surgery, the number of robotic surgeries has increased significantly. Hysterectomy is the most common and fastest-growing robotic surgery treatment in the da Vinci system. With the FDA's clearance of the da Vinci robot for gynecologic surgery, the number of minimally invasive abdominal surgeries for pelvic organ prolapse has increased. With over $3.5 billion in sales of its da Vinci systems, equipment, and accessories in 2018, Intuitive Surgical held a little more than 80% of the robotic-assisted surgery system market.

United States Gynecology Robotic Surgery Market - Technology Advancements

Advances in computer science and robotics have aided in overcoming the limitations of traditional laparoscopy, improving surgeon skills, obtaining higher accuracy and precision during difficult surgical operations, and making MIS more widely available. Haptic interfaces are used to replicate and filter hand gestures, allowing surgical tools to be directed. Improved three-dimensional stereoscopic vision, wristed tools that improve dexterity, and tremor cancelling software that promotes surgical precision are all benefits of robotically assisted technology. Robotic-assisted surgery is projected to become more popular, especially among gynecologic oncologists.

United States Gynecology Robotic Surgery Market - End-User Analysis

The US gynecological robotic surgery market is divided into three types of end-users: hospitals and clinics, ambulatory surgical centers (ASCs), and physician's offices. The move from inpatient to outpatient gynecological operations has been enabled by technological developments and a growing emphasis on robotic surgery. This, together with the growing number of ASCs, is likely to propel the industry forward. The increasing use of surgical robots in hospitals, as well as initiatives to reduce the workload of surgeons and other medical staff, are major reasons driving the growth of the hospitals and clinics market.

Impact of COVID-19 on United States Gynecology Robotic Surgery Market

COVID-19 pandemic had a major influence on the healthcare business. It has resulted in the cancellation and postponing of all non-essential, as well as elective dental, surgical, and medical operations. Gynecology robotic operations are also included. The main rationale for this is to reallocate and reserve healthcare resources for patients who are coronavirus positive. According to the American Hospital Association, inpatient volume in hospitals and health systems in the United States decreased by 20% in 2020.

Competitive Landscape

Intuitive Surgical, Inc. commanded most of the market revenue for gynecological robotic surgery in the United States in 2019. The company's high level of skill in robotic surgery and the growing number of da Vinci gynecological treatments are the main reasons for its significant position. TransEnterix Surgical Inc. and Medrobotics Corporation are other major companies in the market. In 2019, TransEntrix's Senhance was used in over 1,600 surgeries around the world, up 194% over 2018. The competitive landscape of the market is likely to change significantly in the future years because of increasing R&D expenditure by firms like CMR Surgical Ltd., Medtronic, and Titan Medical Inc. to penetrate the US market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of United States Gynecology Robotic Surgery Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in United States Gynecology Robotic Surgery Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.